NCT07215936

Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

Dose_dense Capecitabine Schedule [7days on _7days Off] in Colorectal Cancer in Comparison With Standered Regimen

• Status: Active Not Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Dose\_dense Capecitabine Schedule in colorectal cancers

Detailed description

Dose\_dense Capecitabine schedule\[7 days on\_7days off\] in colorectal cancer in comparison with standerd regimen

Conditions

• Colorectal Cancer

Interventions

Type	Name	Description
DRUG	Arm A:Dose_dense Capecitabine in Colorectal cancer	Appling dose \_dense Capecitabine 1750mg/m2 for one week then one week off Cycle repeated every 2 weeks
DRUG	Arm B : standard dose Capecitabine	Pateints will receive capecitabine 1000 mg/m2 for 2 weeks then one week off

Timeline

• Start date: 2025-09-25
• Primary completion: 2027-09-01
• Completion: 2028-09-01
• First posted: 2025-10-14
• Last updated: 2025-10-14

Locations

1 site across 1 country: Egypt

Regulatory

• FDA-regulated drug study